METHODS AND COMPOSITIONS USING CAP43 PROTEINS AND NUCLEIC ACIDS TO DIAGNOSE AND TREAT CANCER AND OTHER DISORDERS

Details for Australian Patent Application No. 2002243640 (hide)

Owner NEW YORK UNIVERSITY

Inventors COSTA, Max; SALNIKOW, Konstantin; YEE, Herman

Pub. Number AU-A-2002243640

PCT Pub. Number WO2002/058719

Priority 60/264,268 25.01.01 US

Filing date 25 January 2002

Wipo publication date 6 August 2002

International Classifications

A61K 038/00 Medicinal preparations containing peptides

C07K 005/00 Peptides having up to four amino acids in a fully defined sequence

C07K 007/00 Peptides having 5 to 20 amino acids in a fully defined sequence

C07H 005/04 Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

C07H 005/06 Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

C07H 019/00 Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 021/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/48 Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/567 Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 033/543 Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

C07K 001/00 General processes for the preparation of peptides

C07K 014/00 Peptides having more than 20 amino acids

C07K 017/00 Carrier-bound or immobilised peptides

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 002/00 Peptides of undefined number of amino acids

C07K 004/00 Peptides having up to 20 amino acids in an undefined or only partially defined sequence

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002243640

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002243641-HIGH-THROUGHPUT BIOMOLECULAR CRYSTALLISATION AND BIOMOLECULAR CRYSTAL SCREENING

2002243639-SUPPLEMENTAL BILGE FILTRATON SYSTEM